Comprehensive guide to research methodology, clinical trials, ethics, evidence-based practice, and GCC research landscape — aligned with DHA, DOH, and SCFHS exam requirements.
Research Paradigms
Quantitative Research
RCT (Randomised Controlled Trial): Participants randomly assigned to intervention or control; gold standard for causality
Cohort Study: Follow exposed vs. unexposed groups over time; prospective or retrospective
Case-Control Study: Compare those with outcome (cases) to those without (controls); identifies risk factors
Cross-Sectional Study: Snapshot at one point in time; measures prevalence; cannot establish causality
Qualitative Research
Phenomenology: Lived experience of individuals; explores meaning of a phenomenon
Grounded Theory: Develops theory grounded in data; uses constant comparative analysis
Ethnography: Studies culture and social practices through immersion and observation
Thematic Analysis: Identifies, analyses and reports patterns (themes) within qualitative data
Evidence Hierarchy
Levels of Evidence (Oxford CEBM / GRADE)
Level I
Systematic Review / Meta-Analysis — Synthesises all available RCTs; highest confidence; GRADE "high"
Cohort Study — Observational; good for prognosis and aetiology; less subject to bias than case-control
Level IV
Case-Control / Case Series — Retrospective; useful for rare outcomes; susceptible to recall bias
Level V
Expert Opinion / Consensus — Lowest level; used when no other evidence exists
PICO Framework
Formulating a Research Question
P
Population / Patient
Who are the patients? What is the condition?
I
Intervention
What is the exposure or treatment?
C
Comparison
What is the alternative (control, placebo)?
O
Outcome
What is the measured result or endpoint?
Example PICO: In adult ICU patients (P), does nurse-led daily sedation interruption (I) compared to continuous sedation (C) reduce mechanical ventilation duration (O)?
Research Process
Steps in the Research Process
1. Identify Question
→
2. Literature Review
→
3. Study Design
→
4. Ethics Approval
→
5. Data Collection
→
6. Analysis
→
7. Dissemination
Key Statistical Terms
Essential Terminology
Term
Definition
Clinical Significance
Hypothesis
Testable prediction about relationship between variables
Guides study design and data collection
Null Hypothesis (H₀)
Assumes no difference or effect between groups
The assumption being tested; rejected when p < 0.05
P-value
Probability of observed results if null hypothesis is true
p < 0.05 = statistically significant (5% threshold)
Confidence Interval (CI)
Range within which true value likely falls (usually 95%)
Narrow CI = more precise estimate
Statistical Power
Probability of detecting a true effect (typically ≥ 80%)
Low power → risk of Type II error (false negative)
Sample Size Calculation
Calculated before study; considers power, α, effect size
Ensures study has sufficient participants to detect effect
Randomisation
Random assignment to groups; reduces selection bias
Essential for RCT validity
Blinding
Concealing group allocation from participants/researchers
Reduces performance and detection bias
Type I Error (α): Rejecting a true null hypothesis (false positive). Type II Error (β): Failing to reject a false null hypothesis (false negative). Power = 1 − β.
Allocation Concealment: Prevents foreknowledge of assignment (SNOSE, central randomisation); reduces selection bias
Blinding (Masking)
Single-blind: Participant unaware of allocation; researcher aware
Double-blind: Both participant and researcher unaware; reduces performance and detection bias
Triple-blind: Participant, researcher, and outcome assessor/statistician all blinded
Open-label: No blinding; necessary when blinding is impractical (e.g., surgical interventions)
Analysis Populations
Intention-to-Treat (ITT): Analyses all randomised participants in assigned groups regardless of protocol deviation or withdrawal. Preserves randomisation; preferred for primary analysis; reflects real-world effectiveness.
Per-Protocol (PP): Analyses only participants who adhered fully to the protocol. More likely to show efficacy under ideal conditions; subject to bias if dropouts are non-random.
Clinical Trial Team Roles
Key Personnel
Role
Responsibilities
Principal Investigator (PI)
Physician accountable for study conduct; signs off on eligibility, consent, protocol decisions
Co-Investigator
Supports PI; may conduct study procedures and assessments
Adverse Event (AE): Any untoward medical occurrence in a clinical trial participant. Does not necessarily have a causal relationship with the intervention.
Rights, safety and wellbeing of trial subjects must be protected above all other interests
Available nonclinical and clinical information must support the proposed trial
Trials must be scientifically sound and described in a clear, detailed protocol
Informed consent must be obtained freely before participation
Records must be accurate and verifiable (audit trail); source documents must support CRF data
Systems must be in place to ensure quality of all aspects of the trial (ALCOA: Attributable, Legible, Contemporaneous, Original, Accurate)
CONSORT Statement: Consolidated Standards of Reporting Trials — 25-item checklist and flow diagram for transparent reporting of parallel-group RCTs. Required by most peer-reviewed journals.
Foundational Ethical Frameworks
Declaration of Helsinki (WMA)
Guides ethical conduct of human medical research; adopted 1964, last revised 2013
Distinguishes therapeutic research from non-therapeutic research
Requires IRB/REC approval for all human research
Informed consent mandatory; special protections for vulnerable populations
Negative results must be published or made available (publication bias)
Research protocols must be registered in publicly accessible databases
Belmont Report (USA, 1979)
Respect for Persons (Autonomy): Individuals should be treated as autonomous agents; those with diminished autonomy require protection
Beneficence: Maximise possible benefits and minimise harms; "do no harm"
Justice: Fair distribution of research burdens and benefits; no exploitation of vulnerable groups
These three principles underpin modern research ethics committees worldwide, including GCC countries.
Informed Consent
Essential Elements of Valid Informed Consent
Purpose and nature of the study
All foreseeable risks and discomforts
Expected benefits to participant or others
Alternative procedures/treatments available
Extent of confidentiality protection
Voluntary participation — right to withdraw at any time without penalty
Contact information for questions about study and participant rights
Any compensation or treatment available if injury occurs
Disclosure of significant new findings during the study
Capacity Assessment: Participant must understand information, retain it, weigh up options, and communicate a decision. Use a Legally Authorised Representative (LAR) when participant lacks capacity (e.g., unconscious patients, minors). Document capacity assessment.
Avoid coercion; benefits must not create undue inducement; limited protocol types allowed
Pregnant Women
Risk to foetus must be minimal; direct benefit to mother required; partner consent not required
Cognitively Impaired
LAR must provide permission; participant assent sought where possible; ongoing reassessment
Economically Disadvantaged
Compensation must not unduly influence; ensure research benefits accessible to community
IRB/REC Submission
Research Ethics Committee Requirements
Full study protocol with version number and date
Investigator's Brochure (IB) or product information
Informed consent form and participant information sheet
Recruitment materials (advertisements, scripts)
CVs of all investigators
Insurance/indemnity certificates
Data management and confidentiality plan
Budget and funding source disclosure
Data Protection
GDPR Principles & Research Data Security
Lawfulness, Fairness, Transparency: Data processed with legal basis; participants informed
Purpose Limitation: Data collected for specified research purposes only
Data Minimisation: Only necessary data collected
Accuracy: Data kept accurate and up to date
Storage Limitation: Retained only as long as necessary (typically 5–15 years post-trial)
Pseudonymisation: Replace identifiers with codes; link file held separately and securely
Anonymisation: Irreversible removal of identifiers; data no longer subject to GDPR
Data Security: Technical and organisational measures; access controls; encrypted storage
Research Misconduct
Fabrication, Falsification, Plagiarism (FFP)
Fabrication: Making up data or results and recording or reporting them as if real.
Falsification: Manipulating research materials, equipment, or processes; altering or omitting data.
Plagiarism: Appropriating another's ideas, processes, results, or words without giving credit.
GCC Research Ethics
Ethics Landscape in GCC Countries
Country / Body
Key Regulatory Authority
Saudi Arabia
Saudi National Bioethics Committee (NBC); KACST; MOH Research Ethics; KAIMRC IRB
UAE
Human Research Ethics Committee (HREC) — DHA; DOH Abu Dhabi; MOHAP HREC
Qatar
Institutional Biosafety Committee (IBC); HMC IRB; Qatar Foundation research ethics
Kuwait
Ministry of Health Ethics Committee; Kuwait Institute for Medical Specialisation
Bahrain
Ministry of Health Research Ethics Committee; Arabian Gulf University IRB
Oman
Sultan Qaboos University Ethics Committee; Ministry of Health Research & Ethics
Islamic Ethics in Research: Research must serve the public good (maslaha); permissible when benefits outweigh harms; respect for human dignity (karama); patient autonomy; special protection for the vulnerable; scholarly consensus (ijma) sought for novel ethical dilemmas.
EBP Process
Five Steps of Evidence-Based Practice
1. Ask (PICO)
→
2. Acquire Evidence
→
3. Appraise Critically
→
4. Apply to Practice
→
5. Audit Outcomes
Ask: Convert clinical uncertainty into structured PICO question
Acquire: Systematic database search (PubMed, CINAHL, Cochrane) using keywords and MeSH terms
Appraise: Critically evaluate validity, results, and applicability using CASP or other tools
Apply: Integrate evidence with clinical expertise and patient values; adapt to local context
Audit: Monitor outcomes after implementation; measure impact on patient care
GRADE: Grading of Recommendations Assessment, Development and Evaluation. Rates evidence quality: High → Moderate → Low → Very Low based on risk of bias, inconsistency, indirectness, imprecision, publication bias.
Clinical Practice Guidelines & EBP Models
Guidelines & Implementation Frameworks
NICE (UK): National Institute for Health and Care Excellence; rigorous guideline development
WHO: Global guidelines; essential medicines; infection prevention
MOH Saudi Arabia: National clinical practice guidelines; treatment protocols
DHA (Dubai): Health regulation; clinical governance frameworks
DOH (Abu Dhabi): Healthcare standards; quality and patient safety requirements
Iowa Model: Triggers (problem or knowledge-focused) → team assembled → evidence appraised → pilot change → evaluate outcomes → sustain or abandon
Johns Hopkins Model: PET — Practice question, Evidence, Translation; three-step process for nurses
Barriers to EBP: Time constraints, lack of database skills, limited access to journals, resistance to change, workload
Facilitators: Supportive leadership, EBP mentors, journal clubs, protected research time
Writing for Publication
IMRaD Structure
Section
Content
Key Elements
Introduction
Background and rationale
Why was the study needed? Literature gap. Study aim and hypothesis.
Chronic Disease: Diabetes (highest global prevalence in GCC), obesity, cardiovascular disease management
Cultural Competence: Culturally sensitive care models for diverse expatriate and local populations
Workforce Development: Nationalisation (Saudisation, Emiratisation) of nursing; retention strategies
Mental Health: Stigma, access to services, workplace wellbeing
Patient Outcomes: Nurse-sensitive indicators; care quality metrics
Technology: EHR implementation, telehealth, AI in clinical decision support
GCC Research Landscape
Research Institutions & Funding in GCC
Institution / Fund
Country
Focus
KAIMRC — King Abdullah International Medical Research Center
Saudi Arabia
Clinical research; nursing research; health technology assessment; linked to NGHA hospitals
KFSH&RC — King Faisal Specialist Hospital & Research Centre
Saudi Arabia
Oncology, transplantation, genetics; leading clinical trial centre
Qatar National Research Fund (QNRF)
Qatar
Competitive grants; HMC collaborative research; QU and Weill Cornell Medicine Qatar
Hamad Medical Corporation (HMC)
Qatar
Largest healthcare provider; active research and trials programme; nursing research unit
Cleveland Clinic Abu Dhabi (CCAD)
UAE
International collaboration; clinical trials; academic medicine model
UAE University / CMHS
UAE
Health sciences research; nursing faculty research output
Arabian Gulf University (AGU)
Bahrain (regional)
GCC-wide health professions education and research
Research Nurse Career in GCC
Career Development Pathways
Entry Level: Clinical Research Coordinator (CRC) / Research Nurse — executes protocols, manages participants, completes CRFs
Mid-Level: Senior Research Nurse / Lead CRC — mentors juniors, manages multiple studies, contributes to protocol development
Advanced Practice: Research Nurse Specialist / EBP Specialist — leads evidence appraisal, guideline development, site management
Leadership: Research Nurse Manager / Director of Research — strategic oversight, budget management, regulatory relationships
Credentials: CCRP (Certified Clinical Research Professional — SOCRA); CCRA (ACRP); GCP certification; ICH E6 training
Licensing: DHA/DOH/SCFHS licensure required; research nurse role increasingly recognised as specialist category
DHA / DOH / SCFHS Exam Focus Areas
Key Exam Topics — Research & EBP
Levels of evidence and strength of recommendation grading
PICO question formulation
Types of research study designs and their limitations
Ethical principles: Belmont Report, Helsinki Declaration
Informed consent elements and capacity assessment
Interpretation of p-value, CI, RR, OR, NNT, NNH
Critical appraisal of RCTs and systematic reviews
EBP models (Iowa, Johns Hopkins, Stetler)
Research vs. audit vs. quality improvement
Research misconduct definitions (FFP)
Practice MCQs
1. A nurse wants to determine whether a new pressure injury prevention protocol reduces incidence compared to standard care. Using the PICO framework, which element does "standard care" represent?
Population
Intervention
Comparison
Outcome
Standard care (or placebo, or no intervention) is the Comparison component of PICO. The new protocol = Intervention; pressure injury incidence = Outcome; hospitalised adults at risk = Population.
2. Which level of evidence provides the STRONGEST support for a clinical practice change?
Systematic review with meta-analysis of RCTs
Single large RCT with blinding
Prospective cohort study
Expert consensus opinion
Systematic reviews with meta-analysis synthesise all available RCT evidence, representing Level I — the highest level of evidence in the evidence hierarchy. Expert opinion is Level V (lowest).
3. During a clinical trial, a participant experiences a hospitalisation that was NOT anticipated in the protocol. The research nurse should FIRST:
Wait until the next scheduled visit to document it
Report it to the PI immediately and document as an SAE
Complete the CRF and file it without notifying the PI
Discontinue the participant from the study
Hospitalisation meets the definition of a Serious Adverse Event (SAE). GCP requires immediate reporting to the PI and sponsor within required timelines (typically 24 hours). The PI makes the decision about discontinuation.
4. The Number Needed to Treat (NNT) for a new antibiotic is 8. This means:
8% of patients benefit from the antibiotic
The antibiotic reduces mortality by 8%
8 patients must be treated to prevent one additional adverse outcome
The antibiotic is 8 times more effective than the comparator
NNT = 1 ÷ Absolute Risk Reduction. An NNT of 8 means that 8 patients need to be treated with the new antibiotic to prevent one additional case of the outcome compared to the control. Lower NNT = more effective treatment.
5. Which ethical principle from the Belmont Report requires that the benefits and burdens of research be distributed fairly across society?
Respect for persons
Beneficence
Justice
Autonomy
Justice requires the fair distribution of research burdens and benefits. Historically, vulnerable populations were exploited as research subjects while benefits went to others — Justice prevents this. Autonomy/Respect for Persons is about informed decision-making; Beneficence is about maximising benefit and minimising harm.
6. A researcher manipulates data values to achieve statistical significance. This constitutes:
Fabrication
Falsification
Plagiarism
Conflict of interest
Falsification involves manipulating research materials, equipment, or processes, or altering or omitting data. Fabrication is making up data that was never collected. Plagiarism is appropriating others' work without attribution.
7. In an RCT, Intention-to-Treat (ITT) analysis includes:
Only participants who completed the full protocol
Only participants who received the correct dose
Participants who withdrew due to adverse events only
All randomised participants in their originally assigned groups
ITT analysis includes ALL participants as randomised, regardless of whether they completed the study, crossed over, or deviated from protocol. This preserves the benefits of randomisation and reflects real-world effectiveness. Per-protocol analysis only includes completers and is subject to bias.
8. A screening test for a disease has a sensitivity of 95% and specificity of 60%. What does the low specificity indicate?
The test misses many true cases of disease
The test is excellent at ruling in disease
The test produces a high rate of false positive results
The test has a high negative predictive value
Low specificity (60%) means the test correctly identifies only 60% of those WITHOUT the disease — 40% of healthy people will test positive (false positives). High sensitivity (95%) means the test correctly identifies 95% of those WITH the disease (few false negatives). The mnemonic SpPin: high Specificity rules in disease.
9. Which research database is MOST specific to nursing and allied health literature?
PubMed/MEDLINE
CINAHL
Embase
Cochrane Library
CINAHL (Cumulative Index to Nursing and Allied Health Literature) is the primary database for nursing research. It indexes nursing journals, grey literature, and dissertations not found in PubMed. PubMed covers broader biomedical science; Embase focuses on pharmacology; Cochrane focuses on systematic reviews and RCTs.
10. A hospital quality team conducts monthly hand hygiene audits and compares results to WHO standards. This is best classified as:
A cohort research study
Service evaluation
Clinical audit
A quasi-experimental study
Clinical audit involves measuring current practice against a defined standard (WHO guidelines in this case) to identify gaps and drive improvement. It does not generate new knowledge, does not require ethics committee approval, and follows the audit cycle: standard → measure → compare → improve → re-measure.
Evidence Level Classifier Tool
Evidence Level Classifier
Answer the questions below to classify your study design and determine its level of evidence.